Real-time enrollment status for this atopic dermatitis clinical trial
Current Status
Recruiting
Checked: July 23, 2026 at 4:33 AM UTC
| NCT Number | NCT06055361 |
| Recruiting Status | Recruiting |
| Condition | Atopic Dermatitis |
| Phase | PHASE1 |
| Target Enrollment | 45 participants |
| Active Locations | 3 sites in the US |
| Sponsor | Brexogen Inc. |
| Last Updated on CT.gov | September 19, 2025 (Sep 19, 2025) |
As of July 23, 2026: Clinical trial NCT06055361 is currently recruiting participants. This phase1 study for atopic dermatitis is actively seeking new participants at 3 locations across the United States. The study is sponsored by Brexogen Inc.. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT06055361 is actively recruiting participants as of July 23, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 3 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06055361 was last updated Sep 19, 2025 (September 19, 2025). HelloStudys verifies this status automatically.